+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Computational Pathology Market Size, Share & Trends Analysis Report by Component (Software, Services), Application (Disease Diagnosis, Drug Discovery & Development), Technology, End-use, and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 100 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 6085879
REQUEST CUSTOMIZATION
Description Jump to:
The global computational pathology market size was estimated at USD 728.68 Million in 2025 and is projected to reach USD 1.44 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033. The growth is attributed to the rising integration of machine learning and artificial intelligence (AI) technologies, the increasing demand for advanced solutions for faster diagnosis, the rising prevalence of chronic diseases, and increasing investment in healthcare by market players focused on developing advanced solutions.

The computational pathology market is predominantly propelled by the increasing incidence of chronic diseases, notably cancer. The high prevalence of cancer necessitates pathologists to utilize pathology data that can aid in tailoring personalized therapies for patients. Thereby, digital pathology is increasingly being preferred by pathologists, as it accelerates the rate of diagnosis, increases diagnostic accuracy, and provides therapeutic recommendations to improve patient outcomes. For instance, according to a study published in the Journal of Pathology in August 2023, deep learning and artificial intelligence (AI) algorithms to analyze and interpret histopathology images promises substantial improvements in diagnostic accuracy and efficiency, especially for cancer diagnosis and prognosis.

The incorporation of machine learning and AI technologies into pathology workflows significantly transforms the diagnostic process. For instance, in October 2024, Proscia introduced digital pathology toolkits designed to facilitate the development of AI models. These tools enable life science researchers to convert biopsy slide images into quantitative data for training foundation models, improving biomarker discovery, and diagnostics. The development of such solutions enables the rapid and accurate analysis of images, allowing pathologists to identify patterns that may indicate disease progression. By automating routine tasks, AI enables pathologists to focus on more complex diagnostic challenges, thereby improving efficiency and accuracy. This shift enhances diagnostic precision and supports the development of personalized medicine through predictive modeling.

Global Computational Pathology Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global computational pathology market report based on component, application, technology, end use, and region:

Component Outlook (Revenue, USD Million, 2021-2033)

  • Software
  • Services

Application Outlook (Revenue, USD Million, 2021-2033)

  • Disease Diagnosis
  • Drug Discovery & Development
  • Academic Research

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Machine Learning (ML)
  • Natural Language Processing (NLP) Models
  • Computer Vision
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Diagnostic Labs
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Other

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional scope
1.1.2. Component
1.1.3. Technology
1.1.4. Application
1.1.5. End Use
1.1.6. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component
2.2.2. Technology
2.2.3. Application
2.2.4. End Use
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Computational Pathology Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.1.1. Increasing prevalence of chronic diseases
3.1.1.2. Higher cost-efficiency
3.1.1.3. Rapid technological advancements in the computational pathology
3.1.1.4. Emergence of Quantitative Continuous Scoring (QCS) in digital pathology
3.1.2. Market restraint analysis
3.1.2.1. Lack of reimbursement for computational pathology-enabled services
3.1.2.2. Data security and privacy
3.1.3. Market Opportunity Analysis
3.1.4. Market Challenge Analysis
3.2. Computational Pathology Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
3.2.3. Technology Trends Analysis
3.2.4. Case Study Analysis
Chapter 4. Computational Pathology Market: Component Estimates & Trend Analysis
4.1. Component Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Computational Pathology Market by Component Outlook
4.4. Software
4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.5. Services
4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 5. Computational Pathology Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Computational Pathology Market by Application Outlook
5.4. Disease Diagnosis
5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.5. Drug Discovery & Development
5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.6. Academic Research
5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 6. Computational Pathology Market: Technology Estimates & Trend Analysis
6.1. Technology Market Share, 2024 & 2033
6.2. Segment Dashboard
6.3. Global Computational Pathology Market by Technology Outlook
6.4. Machine Learning (ML)
6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.4.2. Deep Learning
6.4.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.4.3. Supervised
6.4.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.4.4. Unsupervised
6.4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.4.5. Others
6.4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.5. Natural Language Processing (NLP) Models
6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.6. Computer Vision
6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.7. Others
6.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. Computational Pathology Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2024 & 2033
7.2. Segment Dashboard
7.3. Global Computational Pathology Market by End Use Outlook
7.4. Hospitals and Diagnostic Labs
7.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
7.5. Biotechnology and Pharmaceutical Companies
7.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
7.6. Academic and Research Institutes
7.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
7.7. Others
7.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 8. Computational Pathology Market: Regional Estimates & Trend Analysis, by Component, by Application, by Technology, by End Use
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. U.S. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Asia-Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory framework
8.9.1.3. Competitive scenario
8.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share/position analysis, 2024
9.4. Company Profiles
9.4.1. Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
9.4.1.1. Company overview
9.4.1.2. Financial Performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Hamamatsu Photonics K.K.
9.4.2.1. Company overview
9.4.2.2. Financial Performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Koninklijke Philips N.V.
9.4.3.1. Company overview
9.4.3.2. Financial Performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Olympus Corporation
9.4.4.1. Company overview
9.4.4.2. Financial Performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. F. Hoffmann-La Roche Ltd.
9.4.5.1. Company overview
9.4.5.2. Financial Performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Aiforia/ Aiforia Technologies PLC
9.4.6.1. Company overview
9.4.6.2. Financial Performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Epredia (3DHISTECH Ltd.)
9.4.7.1. Company overview
9.4.7.2. Financial Performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Visiopharm A/S
9.4.8.1. Company overview
9.4.8.2. Financial Performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Proscia Inc.
9.4.9.1. Company overview
9.4.9.2. Financial Performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Mindpeak GmbH
9.4.10.1. Company overview
9.4.10.2. Financial Performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Akoya Biosciences, Inc. (a Quanterix company)
9.4.11.1. Company overview
9.4.11.2. Financial Performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Paige AI, Inc.
9.4.12.1. Company overview
9.4.12.2. Financial Performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. CellaVision
9.4.13.1. Company overview
9.4.13.2. Financial Performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. AetherAI
9.4.14.1. Company overview
9.4.14.2. Financial Performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives
9.4.15. Qritive
9.4.15.1. Company overview
9.4.15.2. Financial Performance
9.4.15.3. Product benchmarking
9.4.15.4. Strategic initiatives
9.4.16. IBEX (IBEX MEDICAL ANALYTICS)
9.4.16.1. Company overview
9.4.16.2. Financial Performance
9.4.16.3. Product benchmarking
9.4.16.4. Strategic initiatives
9.4.17. Nucleai, Inc.
9.4.17.1. Company overview
9.4.17.2. Financial Performance
9.4.17.3. Product benchmarking
9.4.17.4. Strategic initiatives
List of Fures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Computational Pathology Market outlook
Figure 9 Computational Pathology competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Computational Pathology Market driver impact
Figure 15 Computational Pathology Market restraint impact
Figure 16 Computational Pathology Market strategic initiatives analysis
Figure 17 Computational Pathology Market: Component movement analysis
Figure 18 Computational Pathology Market: Component outlook and key takeaways
Figure 19 Software market estimates and forecast, 2021-2033
Figure 20 Services market estimates and forecast, 2021-2033
Figure 21 Computational Pathology Market: Application movement analysis
Figure 22 Computational Pathology Market: Application outlook and key takeaways
Figure 23 Disease diagnosis market estimates and forecast, 2021-2033
Figure 24 Drug discovery & development market estimates and forecast, 2021-2033
Figure 25 Academic research market estimates and forecast, 2021-2033
Figure 26 Computational Pathology Market: Technology movement analysis
Figure 27 Computational Pathology Market: Technology outlook and key takeaways
Figure 28 Machine Learning (ML) market estimates and forecast, 2021-2033
Figure 29 Deep Learning market estimates and forecast, 2021-2033
Figure 30 Supervised market estimates and forecast, 2021-2033
Figure 31 Unsupervised market estimates and forecast, 2021-2033
Figure 32 Others market estimates and forecast, 2021-2033
Figure 33 Natural Language Processing (NLP) models market estimates and forecast, 2021-2033
Figure 34 Computer vision market estimates and forecast, 2021-2033
Figure 35 Others market estimates and forecast, 2021-2033
Figure 36 Computational Pathology Market: End use movement analysis
Figure 37 Computational Pathology Market: End use outlook and key takeaways
Figure 38 Hospitals and Diagnostic Labs market estimates and forecast, 2021-2033
Figure 39 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2021-2033
Figure 40 Academic and Research Institutes market estimates and forecast, 2021-2033
Figure 41 Other market estimates and forecast, 2021-2033
Figure 42 Global Computational Pathology Market: Regional movement analysis
Figure 43 Global Computational Pathology Market: Regional outlook and key takeaways
Figure 44 Global Computational Pathology Market share and leading players
Figure 45 North America market share and leading players
Figure 46 Europe market share and leading players
Figure 47 Asia-Pacific market share and leading players
Figure 48 Latin America market share and leading players
Figure 49 Middle East & Africa market share and leading players
Figure 50 North America market estimates and forecasts, 2021-2033
Figure 51 U S market estimates and forecasts, 2021-2033
Figure 52 Canada market estimates and forecasts, 2021-2033
Figure 53 Mexico market estimates and forecasts, 2021-2033
Figure 54 Europe market estimates and forecasts, 2021-2033
Figure 55 UK market estimates and forecasts, 2021-2033
Figure 56 Germany market estimates and forecasts, 2021-2033
Figure 57 France market estimates and forecasts, 2021-2033
Figure 58 Italy market estimates and forecasts, 2021-2033
Figure 59 Spain market estimates and forecasts, 2021-2033
Figure 60 Denmark market estimates and forecasts, 2021-2033
Figure 61 Sweden market estimates and forecasts, 2021-2033
Figure 62 Norway market estimates and forecasts, 2021-2033
Figure 63 Asia-Pacific market estimates and forecasts, 2021-2033
Figure 64 China market estimates and forecasts, 2021-2033
Figure 65 Japan market estimates and forecasts, 2021-2033
Figure 66 India market estimates and forecasts, 2021-2033
Figure 67 Thailand market estimates and forecasts, 2021-2033
Figure 68 South Korea market estimates and forecasts, 2021-2033
Figure 69 Australia market estimates and forecasts, 2021-2033
Figure 70 Latin America market estimates and forecasts, 2021-2033
Figure 71 Brazil market estimates and forecasts, 2021-2033
Figure 72 Argentina market estimates and forecasts, 2021-2033
Figure 73 Middle East and Africa market estimates and forecasts, 2021-2033
Figure 74 South Africa market estimates and forecasts, 2021-2033
Figure 75 Saudi Arabia market estimates and forecasts, 2021-2033
Figure 76 UAE market estimates and forecasts, 2021-2033
Figure 77 Kuwait market estimates and forecasts, 2021-2033
Figure 78 Market share of key market players- Computational Pathology Market
Figure 79 Key Company Categorization
Figure 80 Company Market Share/Position Analysis, 2024
Figure 81 Strategic Framework
List of Fures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Computational Pathology Market outlook
Figure 9 Computational Pathology competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Computational Pathology Market driver impact
Figure 15 Computational Pathology Market restraint impact
Figure 16 Computational Pathology Market strategic initiatives analysis
Figure 17 Computational Pathology Market: Component movement analysis
Figure 18 Computational Pathology Market: Component outlook and key takeaways
Figure 19 Software market estimates and forecast, 2021-2033
Figure 20 Services market estimates and forecast, 2021-2033
Figure 21 Computational Pathology Market: Application movement analysis
Figure 22 Computational Pathology Market: Application outlook and key takeaways
Figure 23 Disease diagnosis market estimates and forecast, 2021-2033
Figure 24 Drug discovery & development market estimates and forecast, 2021-2033
Figure 25 Academic research market estimates and forecast, 2021-2033
Figure 26 Computational Pathology Market: Technology movement analysis
Figure 27 Computational Pathology Market: Technology outlook and key takeaways
Figure 28 Machine Learning (ML) market estimates and forecast, 2021-2033
Figure 29 Deep Learning market estimates and forecast, 2021-2033
Figure 30 Supervised market estimates and forecast, 2021-2033
Figure 31 Unsupervised market estimates and forecast, 2021-2033
Figure 32 Others market estimates and forecast, 2021-2033
Figure 33 Natural Language Processing (NLP) models market estimates and forecast, 2021-2033
Figure 34 Computer vision market estimates and forecast, 2021-2033
Figure 35 Others market estimates and forecast, 2021-2033
Figure 36 Computational Pathology Market: End use movement analysis
Figure 37 Computational Pathology Market: End use outlook and key takeaways
Figure 38 Hospitals and Diagnostic Labs market estimates and forecast, 2021-2033
Figure 39 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2021-2033
Figure 40 Academic and Research Institutes market estimates and forecast, 2021-2033
Figure 41 Other market estimates and forecast, 2021-2033
Figure 42 Global Computational Pathology Market: Regional movement analysis
Figure 43 Global Computational Pathology Market: Regional outlook and key takeaways
Figure 44 Global Computational Pathology Market share and leading players
Figure 45 North America market share and leading players
Figure 46 Europe market share and leading players
Figure 47 Asia-Pacific market share and leading players
Figure 48 Latin America market share and leading players
Figure 49 Middle East & Africa market share and leading players
Figure 50 North America market estimates and forecasts, 2021-2033
Figure 51 U S market estimates and forecasts, 2021-2033
Figure 52 Canada market estimates and forecasts, 2021-2033
Figure 53 Mexico market estimates and forecasts, 2021-2033
Figure 54 Europe market estimates and forecasts, 2021-2033
Figure 55 UK market estimates and forecasts, 2021-2033
Figure 56 Germany market estimates and forecasts, 2021-2033
Figure 57 France market estimates and forecasts, 2021-2033
Figure 58 Italy market estimates and forecasts, 2021-2033
Figure 59 Spain market estimates and forecasts, 2021-2033
Figure 60 Denmark market estimates and forecasts, 2021-2033
Figure 61 Sweden market estimates and forecasts, 2021-2033
Figure 62 Norway market estimates and forecasts, 2021-2033
Figure 63 Asia-Pacific market estimates and forecasts, 2021-2033
Figure 64 China market estimates and forecasts, 2021-2033
Figure 65 Japan market estimates and forecasts, 2021-2033
Figure 66 India market estimates and forecasts, 2021-2033
Figure 67 Thailand market estimates and forecasts, 2021-2033
Figure 68 South Korea market estimates and forecasts, 2021-2033
Figure 69 Australia market estimates and forecasts, 2021-2033
Figure 70 Latin America market estimates and forecasts, 2021-2033
Figure 71 Brazil market estimates and forecasts, 2021-2033
Figure 72 Argentina market estimates and forecasts, 2021-2033
Figure 73 Middle East and Africa market estimates and forecasts, 2021-2033
Figure 74 South Africa market estimates and forecasts, 2021-2033
Figure 75 Saudi Arabia market estimates and forecasts, 2021-2033
Figure 76 UAE market estimates and forecasts, 2021-2033
Figure 77 Kuwait market estimates and forecasts, 2021-2033
Figure 78 Market share of key market players- Computational Pathology Market
Figure 79 Key Company Categorization
Figure 80 Company Market Share/Position Analysis, 2024
Figure 81 Strategic Framework

Companies Mentioned

The leading players profiled in this Computational Pathology market report include:
  • Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
  • Hamamatsu Photonics K.K.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Aiforia/ Aiforia Technologies PLC
  • Epredia (3DHISTECH Ltd.)
  • Visiopharm A/S
  • Proscia Inc.
  • Mindpeak GmbH
  • Akoya Biosciences, Inc. (a Quanterix company)
  • Paige AI, Inc.
  • CellaVision
  • aetherAI
  • Qritive
  • IBEX (IBEX MEDICAL ANALYTICS) Nucleai, Inc.
  • Nucleai, Inc.

Table Information

Report AttributeDetails
No. of Pages100
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 728.68 Million
Forecasted Market Value ( USD ) by 2033 $ 1440 Million
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Computational Pathology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Computational Pathology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Regional Outlook and Forecast, 2025 - 2032 - Product Image

Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Regional Outlook and Forecast, 2025 - 2032

  • Report
  • 352 Pages
  • Global
From
Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospitals, Labs, Pharma/Biotech), & Region - Global Forecast to 2030 - Product Image

Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospitals, Labs, Pharma/Biotech), & Region - Global Forecast to 2030

  • Report
  • 320 Pages
  • Global
From
Artificial Intelligence In Diagnostics Market Size, Share & Trends Analysis Report By Component (Software, Hardware, Services), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Artificial Intelligence In Diagnostics Market Size, Share & Trends Analysis Report By Component (Software, Hardware, Services), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Advanced Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test (Tumor Marker Tests, Fine Needle Aspiration Cytology (FNAC) & Biopsy, Imaging-Based Diagnostics, Bone Marrow Aspiration & Biopsy), End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Advanced Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test (Tumor Marker Tests, Fine Needle Aspiration Cytology (FNAC) & Biopsy, Imaging-Based Diagnostics, Bone Marrow Aspiration & Biopsy), End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.